CVE-2023-3834

Bug Finder EX-RATE Ticket create cross site scripting

Description

A vulnerability was found in Bug Finder EX-RATE 1.0. It has been rated as problematic. Affected by this issue is some unknown functionality of the file /user/ticket/create of the component Ticket Handler. The manipulation of the argument message leads to cross site scripting. The attack may be launched remotely. The identifier of this vulnerability is VDB-235160. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Category

3.5
CVSS
Severity: Low
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: Bug Finder EX-RATE
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.235160 vdb entry technical description third party advisory
https://vuldb.com/?ctiid.235160 permissions required third party advisory signature

Frequently Asked Questions

What is the severity of CVE-2023-3834?
CVE-2023-3834 has been scored as a low severity vulnerability.
How to fix CVE-2023-3834?
To fix CVE-2023-3834, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-3834 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-3834 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-3834?
CVE-2023-3834 affects Bug Finder EX-RATE.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.